Lilly's blood cancer drug meets main goal in late-stage study-March 2024-www.financetom.com

Lilly's blood cancer drug meets main goal in late-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Lilly's blood cancer drug meets main goal in late-stage study

Sep 8, 2025 4:21 AM

Sept 8 (Reuters) - Eli Lilly ( LLY ) said on Monday its

blood cancer treatment Jaypirca met the main goal in a

late-stage study in patients who have not received prior

treatment.

(Reporting by Mariam Sunny in Bengaluru)

Previous page： Form 8.3 - AWE LN Next page： Content Partners LLC Acquires Hoodwinked and Hoodwinked Too! Hood vs. Evil Animated Film Franchise

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Form 8.3 - AWE LN

Oct 28, 2025

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...

Content Partners LLC Acquires Hoodwinked and Hoodwinked Too! Hood vs. Evil Animated Film Franchise

Oct 28, 2025

Acquisition coincides with the 20th anniversary of Hoodwinked, with plans to reintroduce the cult-classic to audiences worldwide LOS ANGELES, Oct. 28, 2025 /PRNewswire/ -- Content Partners LLC, the leading independent owner of major studio-distributed films, television programming, and related participations, today announced that the company has acquired the animated feature films Hoodwinked (2005) and Hoodwinked Too! Hood vs. Evil (2011)...

Form 8.3 - THE PRS REIT PLC

Oct 28, 2025

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...

Form 8.3 - INTERNATIONAL PERSONAL FINANCE PLC

Oct 28, 2025

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...